Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,895 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00604435 | Neoadjuvant Endostatin and Chemotherapy for Breast Cancer | completed | Phase 2 | 69 | Xijing HospitalOTHER | 1 | Jan 20, 2010 | clinicaltrials |
| NCT00518583 | Phase II Study in Patients With Operable Breast Cancer | unknown | Phase 2 | 30 | Aptium Oncology Research NetworkNETWORK | 1 | Jan 15, 2010 | clinicaltrials |
| NCT01043913 |
| Guarana (Paullinia Cupana) for Breast Cancer Chemotherapy-related Fatigue |
| completed |
| Phase 2 |
| 60 |
| Faculdade de Medicina do ABCOTHER |
| 1 |
| Jan 7, 2010 |
| clinicaltrials |
| NCT00002937 | Paclitaxel With or Without PSC 833 in Treating Patients With Metastatic Breast Cancer | completed | Phase 2 | 70 | City of Hope Medical CenterOTHER | 2 | Jan 6, 2010 | clinicaltrials |
| NCT00304850 | Polyamine-free Diet to Prevent Post Surgery Hyperalgesia(PoLyDOL) | completed | Phase 2 | 160 | University Hospital, BordeauxOTHER | 1 | Dec 29, 2009 | clinicaltrials |
| NCT00677326 | Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Breast Cancer | terminated | Phase 1 / Phase 2 | 1 | Tokyo UniversityOTHER | 1 | Dec 29, 2009 | clinicaltrials |
| NCT00678509 | Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Breast Cancer | terminated | Phase 1 / Phase 2 | 14 | Tokyo UniversityOTHER | 1 | Dec 29, 2009 | clinicaltrials |
| NCT00303524 | Comparative Study of Oestradiol Suppression: Zoladex 10.8mg/3 Month vs. 3.6mg/Month in ER +ve EBC Pre-menopausal Patients | completed | Phase 2 | 170 | AstraZenecaINDUSTRY | 1 | Dec 23, 2009 | clinicaltrials |
| NCT00243165 | Lifemel Honey to Reduce Leucopenia During Chemotherapy | unknown | Phase 2 | 60 | Rambam Health Care CampusOTHER | 0 | Dec 7, 2009 | clinicaltrials |
| NCT00434356 | A Study of Sunitinib in Combination With Bevacizumab and Paclitaxel in Previously Untreated Patients With Metastatic Breast Cancer (SABRE-B) | terminated | Phase 2 | 46 | Genentech, Inc.INDUSTRY | 0 | Dec 3, 2009 | clinicaltrials |
| NCT01025349 | Salvage Therapy With Bevacizumab Plus Docetaxel and Cisplatin for Taiwanese Metastatic Breast Cancer | completed | Phase 2 | 20 | Taipei Medical University HospitalOTHER | 1 | Dec 3, 2009 | clinicaltrials |
| NCT00558545 | A Phase 1-2, XIAP Antisense AEG35156 With Weekly Paclitaxel in Patients With Advanced Breast Cancer | terminated | Phase 1 / Phase 2 | 61 | Aegera TherapeuticsINDUSTRY | 1 | Dec 2, 2009 | clinicaltrials |
| NCT00712621 | Determining Quality of Life in Breast Cancer Patient After Completing Radiation,Chemotherapy,Surgery or Combination | withdrawn | Phase 2 | 460 | American Scitech InternationalOTHER | 1 | Nov 24, 2009 | clinicaltrials |
| NCT00190671 | A Study of Pemetrexed and Cyclophosphamide Given Every 21 Days in Advanced Breast Cancer Patients | completed | Phase 1 / Phase 2 | 103 | Eli Lilly and CompanyINDUSTRY | 6 | Nov 20, 2009 | clinicaltrials |
| NCT00191451 | A Study of Gemcitabine and Carboplatin (Plus Herceptin in Human Epidermal Growth Factor Receptor 2 Positive [HER2+] Patients) With Metastatic Breast Cancer | completed | Phase 2 | 150 | Eli Lilly and CompanyINDUSTRY | 1 | Nov 20, 2009 | clinicaltrials |
| NCT00333047 | Letrozole in Metastatic Breast Cancer in Combination With Chemotherapy | completed | Phase 2 / Phase 3 | 24 | NovartisINDUSTRY | 1 | Nov 19, 2009 | clinicaltrials |
| NCT00191815 | Combination Chemotherapy for Metastatic Breast Cancer | completed | Phase 2 | 70 | Eli Lilly and CompanyINDUSTRY | 2 | Nov 11, 2009 | clinicaltrials |
| NCT00617968 | GETNA2 Neoadj. TAX+Femara vs Femara in g I/II Breast Cancer | completed | Phase 2 | 5 | SanofiINDUSTRY | 1 | Sep 2, 2009 | clinicaltrials |
| NCT00002679 | Adjuvant High-Dose, Sequential Chemotherapy in Treating Patients With Resected Breast Cancer | completed | Phase 2 | 89 | Yale UniversityOTHER | 1 | Aug 26, 2009 | clinicaltrials |
| NCT00875355 | Radiation Therapy With or Without Temozolomide in Treating Women With Brain Metastases and Breast Cancer | unknown | Phase 2 | 100 | Institut CurieOTHER | 1 | Aug 26, 2009 | clinicaltrials |
| NCT00770354 | Phase II Study of AS1402 Combined With Letrozole to Treat Breast Cancer | terminated | Phase 2 | 110 | Antisoma ResearchINDUSTRY | 1 | Aug 10, 2009 | clinicaltrials |
| NCT00954135 | Letrozole Plus Oral Cyclophosphamide Plus/Minus Sorafenib as Primary Systemic Treatment in Breast Cancer Patients | unknown | Phase 2 | 190 | University of Turin, ItalyOTHER | 1 | Aug 7, 2009 | clinicaltrials |
| NCT00080743 | Gefitinib With or Without Tamoxifen in Treating Patients With Tamoxifen-Resistant Metastatic Breast Cancer | completed | Phase 2 | 2 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Aug 6, 2009 | clinicaltrials |
| NCT00123929 | Genetic Expression and Prediction of Response to Neoadjuvant Docetaxel or Doxorubicin in Locally Advanced Breast Cancer | completed | Phase 2 | 250 | Hospital San Carlos, MadridOTHER | 1 | Aug 6, 2009 | clinicaltrials |
| NCT00465673 | Liposomal Doxorubicin (Lipo-Dox) in Patients With Brain Metastasis From Breast Cancer | terminated | Phase 2 | 2 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Aug 6, 2009 | clinicaltrials |
| NCT00842998 | Efficacy Study of Single Agent Trastuzumab or Lapatinib to Treat HER2-Overexpressing Breast Cancer(HERLAP) | unknown | Phase 2 | 120 | Azienda Ospedaliera Ordine Mauriziano di TorinoOTHER | 1 | Jun 26, 2009 | clinicaltrials |
| NCT00316199 | Efficacy Study of Gemcitabine-Paclitaxel to Treat Metastatic Breast Cancer | completed | Phase 2 | 60 | Eli Lilly and CompanyINDUSTRY | 1 | Jun 17, 2009 | clinicaltrials |
| NCT00687648 | Cyclophosphamide, Methotrexate, and Prednisolone With or Without Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer | unknown | Phase 2 | 70 | National Cancer Centre, SingaporeOTHER | 1 | Jun 17, 2009 | clinicaltrials |
| NCT00801411 | Cyclophosphamide and Docetaxel or Doxorubicin in Treating Women With Newly Diagnosed Breast Cancer That Can Be Removed by Surgery | unknown | Phase 2 | 318 | National Cancer Centre, SingaporeOTHER | 1 | Jun 17, 2009 | clinicaltrials |
| NCT00919399 | Exemestane (Aromasine) + Tamoxifen - Breast Neo-Adjuvant(TAMARO) | completed | Phase 2 | 15 | Institut Claudius RegaudOTHER | 1 | Jun 12, 2009 | clinicaltrials |
| NCT00287534 | Effectiveness of Combination of Arimidex and Nolvadex in Adjuvant Therapy of Breast Carcinoma in Postmenopausal Women.(ARNO-95) | completed | Phase 2 | 1,059 | AstraZenecaINDUSTRY | 1 | Jun 9, 2009 | clinicaltrials |
| NCT00096668 | Evaluation of Safety and Efficacy of TOCOSOL(R) Paclitaxel as Initial Treatment for Metastatic Breast Cancer | completed | Phase 2 | 47 | Achieve Life SciencesINDUSTRY | 1 | Jun 4, 2009 | clinicaltrials |
| NCT00306631 | A Study to Determine the Antitumor Activity and Evaluate the Safety of MKC-1 | completed | Phase 2 | 65 | CASI pharmaceuticals, Inc.INDUSTRY | 1 | Jun 3, 2009 | clinicaltrials |
| NCT00106002 | Pemetrexed as the First Treatment in Advanced or Metastatic Breast Cancer | completed | Phase 2 | 37 | Eli Lilly and CompanyINDUSTRY | 1 | Jun 1, 2009 | clinicaltrials |
| NCT00063570 | Pemetrexed Plus Gemcitabine in Metastatic Breast Cancer Patients After Receiving Taxane Therapy | completed | Phase 2 | 73 | Eli Lilly and CompanyINDUSTRY | 2 | May 29, 2009 | clinicaltrials |
| NCT00452140 | Phase II Study With the Trifunctional Antibody Ertumaxomab to Treat Metastatic Breast Cancer Progressing After Endocrine Treatment | terminated | Phase 2 | 40 | Neovii BiotechINDUSTRY | 5 | May 19, 2009 | clinicaltrials |
| NCT00036023 | Chemotherapy Related Anemia in Patients With Non-Myeloid Malignancies | completed | Phase 2 | — | AmgenINDUSTRY | 0 | May 11, 2009 | clinicaltrials |
| NCT00087958 | Intravenous RPR109881 in Male or Female Patients With Advanced Breast Cancer Who no Longer Respond to Anthracycline, Taxane and Capecitabine Treatment | completed | Phase 2 | 168 | SanofiINDUSTRY | 15 | May 1, 2009 | clinicaltrials |
| NCT00003135 | Whole Body Hyperthermia Combined With Chemotherapy in Treating Patients With Metastatic Breast, Ovarian, Endometrial, or Cervical Cancer | unknown | Phase 2 | 34 | The University of Texas Health Science Center, HoustonOTHER | 1 | Apr 30, 2009 | clinicaltrials |
| NCT00234403 | A Trial to Evaluate the Combination of Iressa & Faslodex® in Patients With Advanced or Metastatic Breast Cancer | completed | Phase 2 | 60 | AstraZenecaINDUSTRY | 1 | Apr 23, 2009 | clinicaltrials |
| NCT00247481 | ZD1839 (Iressa™) In Combination With Docetaxel As First-Line Treatment In Patients With Metastatic Breast Cancer | completed | Phase 2 | 77 | AstraZenecaINDUSTRY | 1 | Apr 23, 2009 | clinicaltrials |
| NCT00255463 | Phase II Neoadjuvant ER+/PgR + Arimidex +/- Iressa Study | completed | Phase 2 | 185 | AstraZenecaINDUSTRY | 7 | Apr 23, 2009 | clinicaltrials |
| NCT00637026 | Ph II Early BC Pre-Surgical Biologic Study | completed | Phase 2 | 65 | AstraZenecaINDUSTRY | 0 | Apr 23, 2009 | clinicaltrials |
| NCT00632723 | IRESSA™ (Gefitinib) in Breast Cancer Patients | completed | Phase 2 | 54 | AstraZenecaINDUSTRY | 0 | Apr 22, 2009 | clinicaltrials |
| NCT00497458 | Androgen Therapy for Breast Cancer Patients With Aromatase Inhibitor Induced Side-Effects(ART2) | unknown | Phase 2 | 90 | Havah Therapeutics Pty LtdINDUSTRY | 1 | Apr 9, 2009 | clinicaltrials |
| NCT00043368 | PF-3512676 (CPG 7909) Injection For Patients Who Completed An Oncology Study Using PF-3512676 (CPG 7909) | completed | Phase 2 | 31 | PfizerINDUSTRY | 2 | Mar 12, 2009 | clinicaltrials |
| NCT00043394 | CPG 7909 Plus Herceptin® In Patients With Metastatic Breast Cancer | completed | Phase 2 | 16 | PfizerINDUSTRY | 1 | Mar 12, 2009 | clinicaltrials |
| NCT00200824 | Effects of Soy Compounds on Breast Cancer, Prostate Cancer, and Bone Health | completed | Phase 2 | — | National Center for Complementary and Integrative Health (NCCIH)NIH | 1 | Mar 12, 2009 | clinicaltrials |
| NCT00851110 | Adjuvant Breast Cancer Study of the Netherlands Working Party for Autotransplantation in Solid Tumors | terminated | Phase 2 | 50 | University Medical Center GroningenOTHER | 1 | Feb 25, 2009 | clinicaltrials |
Data updated 23 days agoSource updated Jan 20, 2010source: clinicaltrials